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Abstract
Background: Large numbers of vulnerable patients are in need of palliative cancer and dementia care. However, a
wide gap exists between the knowledge of best practices in palliative care and their use in everyday clinical
practice. As part of a European policy improvement program, quality indicators (QIs) have been developed to
monitor and improve the organisation of palliative care for patients with cancer and those with dementia in various
settings in different European countries.
Method: A multidisciplinary, international panel of professionals participated in a modified RAND Delphi procedure
to compose a set of palliative care QIs based on existing sets of QIs on the organisation of palliative care. Panellists
participated in three written rounds, one feedback round and one meeting. The panel’s median votes were used to
identify the final set of QIs.
Results: The Delphi procedure resulted in 23 useful QIs. These QIs represent key elements of the organisation of
good clinical practice, such as the availability of palliative care teams, the availability of special facilities to provide
palliative care for patients and their relatives, and the presence of educational interventions for professionals. The
final set also includes QIs that are related to the process of palliative care, such as documentation of pain and other
symptoms, communication with patients in need of palliative care and their relatives, and end-of-life decisions.
Conclusion: International experts selected a set of 23 QIs for the organisation of palliative care. Although we
particularly focused on the organisation of cancer and dementia palliative care, most QIs are generic and are
applicable for other types of diseases as well.
Keywords: Palliative care, Quality indicators, Dementia, Cancer, Europe
Background
Europe faces a huge challenge with a population that is
rapidly aging in the coming decades. It is estimated that
the incidence and prevalence of cancer will increase by
about 20% and the prevalence of dementia will double
before 2050 [1-4]. Although it concerns two totally
different diseases with different care needs and disease
trajectories, they do have a lot in common: they are
often unnecessarily hospitalized, [5] have a high need for
a multidisciplinary approach [6] and many suffer from
symptoms which are partly the same, like pain [7,8].
Higher survival rates of people with life-threatening
and progressive chronic diseases will result in a larger
number of patients that have multiple and complex
health-threatening problems. Therefore, a growing num-
ber of patients will be in need of palliative care. However,
a wide gap exists between the knowledge of best practice
in palliative cancer and dementia care and its application
in every day clinical practice [9].
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As a first step in bridging this gap, it is important to
assess current performance of palliative care in relation
to its desired performance. Such an assessment of health
care can be achieved by using quality indicators (QIs). QIs
are evidence based, explicitly defined and measurable
items that evaluate and describe structures, processes and
outcomes of health care [10]. As such, they reflect the
core elements of good clinical care. In day-to-day terms
QIs can, for example, show whether pain is regularly being
assessed using a validated tool; or whether a general
practitioner is timely informed about a patient’s situ-
ation before or directly after discharge from hospital
[11,12]. QIs can help trace potential problems or con-
firm good quality of care and can be used to guide
quality improvement processes [10]. They have been
used effectively to assess and improve hospital care,
[13] primary care, [14] and dementia care [15,16]. Sev-
eral studies have also developed QIs to improve the
structures and process needed for the delivery of good
quality palliative cancer or dementia care [11,12,17,18].
However, these studies were performed five or more
years ago, developed large sets of QIs, ranging from 56
to 142 QIs. Furthermore, none of these sets were widely
implemented in everyday clinical practice.
The objective of this study was to integrate existing sets
of QIs into one generic set that can be used to assess and
improve the organisation of palliative care in different ser-
vices and countries. The study was conducted within the
framework of the European IMPACT project (IMplemen-
tation of quality indicators for PAlliative Care sTudy) [19].
Methods
A modified RAND Delphi procedure was used to de-
velop a set of QIs, [20] which is considered an accepted
methodology to develop QIs [10]. Typically, a RAND
Delphi procedure consists of a written and a face-to-face
round [20]. In this study, four written rounds and one
face-to-face round were performed to reach consensus
about the essential aspects regarding the organisation of
palliative care.
Panellists
The IMPACT consortium consists of experts of the pan-
European research group on detection and timely INTER-
vention in DEMentia (Interdem) and the European
Association for Palliative Care (EAPC), all of whom
are stakeholders in their country in palliative cancer
and/or dementia care. The research team was invited
to use their networks to purposefully select panellists
for the modified RAND Delphi procedure. A key se-
lection criteria was that the expert had to have exten-
sive knowledge about palliative care, cancer care or
dementia care. Additionally, experts had to be able to
communicate in English (both verbally and non-verbally)
and were planning to attend the 2012 Congress of the
European Association of Palliative Care (EAPC) in
Trondheim, Norway. Project partners nominated na-
tional and international experts in palliative cancer and
dementia care. All nominated experts were approached
via email (n = 50), forty experts from twelve countries
agreed to participate in the modified RAND Delphi
procedure (Table 1). All participants provided written
informed consent. About half of them were experts in
palliative cancer care and the other half in dementia
care. Twenty-two panellists were active clinicians in
this field (e.g. physician, nurse, psychologist, etc. cur-
rently involved in direct-patient care), the others were
researchers.
Selecting a preliminary set of QIs
A search for existing sets of QIs was conducted in
PubMed. The search strategy was limited to English lit-
erature and consisted of various search terms that re-
ferred to subject-specific keywords describing palliative
care (combined using “or”), as well as (“and”) the assess-
ment of care using QIs (combined using “or”). Synonyms
and medical subheading terms were used to fully include
relevant literature (see Table 2).
Subsequently, references of key papers describing sets
of QIs were hand searched. Additionally, consortium
members of the IMPACT project were asked to nomin-
ate national and international sets of QIs on palliative
cancer and dementia care they considered important.
Two researchers (YE & JvRP) subsequently reviewed all
of the identified QIs independently to determine if the
QIs assessed the structure and process of palliative care
and to structure them according to the domains of the
Table 1 Panellists per country
Country Researcher Clinician
AU 1
BE 1 2
CA 1
CH 2
DE 2 3
ES 1 1
IT 1
NL 8 3
NO 3
PO 1
UK 2 7
US 1
Total = 18 22
AU: Australia, BE: Belgium, CA: Canada, CH: Switzerland, DE: Germany, ES: Spain,
IT: Italy, NL: The Netherlands, NO: Norway, PO: Poland, UK: United Kingdom,
US: United States.
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recommended framework for the organisation of pallia-
tive care of the Council of Europe [21].
First written Delphi-round
For the first written Delphi-round (April 2012), panellists
received a personal invitation for an online questionnaire.
To reduce the large number of identified QIs, panellists
were asked to nominate one QI per domain of palliative
care [22]. Those QIs that were nominated by the panellists
were included in the second round of the modified RAND
Delphi procedure.
Second written Delphi-round
In the second round (May 2012), also via an online
questionnaire, panellists were asked to rate QIs on a 9-
point Likert scale for clarity (1 = not clear at all; 9 = very
clear), usefulness (1 = not useful at all; 9 = very useful),
to rephrase unclear and to add missing QIs. They were
instructed to rate a QI high on usefulness if it: 1) corre-
sponded with a basic quality level; 2) referred to a higher
quality level that would be met only in very good prac-
tices; or 3) was associated with an innovative quality
level which is exceptional at the moment, but could be-
come the optimal quality level in the near future [23].
They were asked to give a low rating on usefulness if a
proposed QI: 1) was too ambiguous or represented an
unrealistically high quality level; 2) did not correspond
with the material, social or cultural conditions of the
situation in their country; or 3) was not in accordance
with the regulations of palliative cancer and dementia
care in their country [23].
Third interactive Delphi-round
A consensus meeting was organised during the EAPC
Congress June 7, 2012 in Trondheim, Norway. The
meeting was chaired by an independent researcher with
the aim to reach consensus on the QIs on which there
was disagreement or where the median score was be-
tween 4 and 6 in the second Delphi round. Participants
received a rating sheet on which the median ratings of
the second Delphi-round of all experts were visible. Par-
ticipants were given 30 minutes to rate the adapted QIs
for usefulness. Next, per QI, participants were asked to
raise their hand if they had rated usefulness 6 or less. If
at least nine (30%) participants raised their hand, [20]
the QI was discussed until consensus was reached.
Fourth written Delphi-round
After the consensus-round, the remaining indicators
were fed back to the panellist with the purpose to valid-
ate the changes that were made (September 2012).
Fifth written Delphi round
In the final step of the QI development process, QIs
were operationalised by the research team into questions
that could be used by healthcare professionals to assess
their organisation of palliative care and identify areas for
improvement. During this process, it appeared that some
QIs were inappropriate or not measurable (e.g. too time
consuming to answer them appropriately). All QIs were
therefore rated for necessity by the IMPACT research
team (October 2012), representing both clinicians and
researchers that also took part in the modified RAND
Delphi procedure. QIs that were considered not neces-
sary after this round, were omitted from the list.
Analysis
QIs with a median rating on the usefulness scale of 7, 8
or 9 without disagreement were considered to have face
validity. Disagreement was defined as: 30% or more of
the panellists rated a single QI in the 1–3 tertile and
more than 30% in the 7–9 tertile. QIs scored with a me-
dian of 1–3 without disagreement were not considered
to have face validity. Because panellists had rated QIs
high on usefulness, only QIs with median ratings of 8 or
9 were considered face valid for the second Delphi-
round. Only QIs that were rated valid by all panellists
were included in the final set [20].
Ethical considerations
The Medical Ethics Committee of the district Arnhem-
Nijmegen has declared that this study doesn’t fall within
the remit of the Medical Research Involving Human
Subjects Act (WMO) (registration number 2012/075).
This means that this study can be carried out without an
approval by an accredited medical ethics committee.
Results
650 QIs were selected from literature [11,16,18,22,24-54].
After having assessed these QIs, 554 were excluded be-
cause they were not about the organisation of palliative
care or because of overlap; the remaining 96 QIs were in-
cluded in a preliminary set of QIs (Figure 1). Of the 40 ex-
perts invited as panellists, 25 (63%) participated. In the
first Delphi round, 65 of the 96 QIs were selected and 13
missing QIs were suggested in an open question in which
panellists were asked if they missed any relevant QI. This
resulted in an adapted list of 78 QIs, which were included
in the second Delphi round.
In the second Delphi-round, 27 (67,5%) of the 40 in-
vited panellists participated. Sixteen QIs were considered
Table 2 Overview of search terms
Palliative care Quality indicators
Terminal care Quality assurance
Hospice care Quality measurement
Cancer care Quality assessment
Dementia care
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to have face validity, 28 were invalid, and six QIs were
added to the list based on suggestions made by the
panellists. The 40 QIs on which there was no agreement
on, were included into the third Delphi round.
In the third Delphi-round, a consensus meeting, 29
(72,5%) of the 40 panellists participated. After having
rated 40 QIs, one was excluded and 10 were discussed.
Of the QIs that were discussed, six were accepted and
four were excluded. Panellists also agreed to merge 11
QIs. Round three therefore resulted in 24 accepted QIs.
The total list of QIs (QIs considered to have face validity
in round two and three) comprised 40 QIs.
In the fourth Delphi-round, panellist provided feed-
back to the remaining set of QIs. This resulted in minor
linguistic changes and the exclusion of three QIs be-
cause they were considered inappropriate by the major-
ity of panellists. The resulting set of QIs, therefore,
consisted of 37 QIs. This list was critically assessed by
members of the IMPACT consortium for their necessity
(round five). Fourteen QIs were considered to be
Figure 1 Modified RAND Delphi procedure. 1Equivocal is defined as all QIs on which there was no agreement: e.g. QIs with 30% or more of
ratings in both the 1–3 tertile and the 7–9 tertile and all indicators with a median rating in the 4–6 tertile. 2At the end of round three, panelists
agreed that 11 QIs could be merged.
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overlapping, inappropriate, or not measurable in pallia-
tive care. The final list of QIs, therefore, consisted of 23
QIs, covering seven domains (Table 3). Key findings
can be summarized as follows:
Access to palliative care
The availability of a dedicated palliative care team was
considered important by almost all panellists in the Del-
phi procedure. They explicitly stated that palliative care
services should not only be available during office hours,
but at all times (day, evening, night and weekends). Fur-
thermore, specific elements of palliative care were con-
sidered important, such as the availability of opioids and
anticipatory medications for symptom control, as well as
the availability of bereavement support.
Almost all panellists also rated important the accessi-
bility of the medical record to health care professionals,
timely transfer of information between settings (includ-
ing when transferring or discharging patients). Panellists
also considered an assigned contact person, who main-
tains regular contact with patients and their families,
useful.
Infrastructure
The infrastructure of the place where palliative care is
provided, such as a single bed hospital room, was rated
important. Access to equipment (such as anti-decubitus
mattresses, suction equipment, etc.), required to provide
palliative care, was considered important. Panellists also
rated high consensus for facilities for relatives to visit,
stay overnight, and a private area for saying goodbye to
the deceased. There was no agreement on QIs that
aimed to control waiting time or waiting list, i.e. these
aspects were not considered to be unique for palliative
care and therefore not important.
Assessment tools
Regular assessment of pain and other symptoms was
rated as a valid quality criterion, though it was commen-
ted that a validated instrument might not always be
available, particularly for specific patient groups (e.g. for
persons with advanced dementia).
Personnel
There was agreement on the need for a multidisciplinary
team, which should consist of at least a physician and
nurse, and have access to a range of supporting disci-
plines, such as: physiotherapist, psychologist, occupa-
tional therapist, social worker, dietician, and chaplain.
Panellists also rated a regular multidisciplinary team
meeting important.
Documentation of clinical data
Panellists recognized the importance of having a well-
structured medical record. However, a QI about the struc-
ture of the medical record was not considered important
by the panellists. Panellists only considered the inclusion of
a medication regimen in the medical record important.
They also considered a timely assessment (within 48 hours)
of pain and other symptoms, psychosocial and spiritual
needs, patient preferences, wishes and needs, and the
patient's capacity to be involved in the decision making
process as important.
Furthermore, almost all panellists rated the documenta-
tion of communication on the medical condition, goals of
treatment, physical, psychosocial, and spiritual needs of
the patient and their relatives, intention to return home,
advanced directive, and end-of-life decisions as important.
Quality and safety
Panellists rated the QI about assessing the experiences
of care givers with the palliative care service important.
Secondly, a QI about the quality of care, assessing the
use of an end-of-life care pathway within the last three
days of life, was also considered useful.
Education
QIs about the staff ’s learning objectives and a program
for specialised and/or continuing medical education
about the physical, psychosocial, and spiritual needs of a
patient in need for palliative care were not rated import-
ant. There was also no agreement on disease-specific
education for staff members, but panellists considered
palliative care training specified to the professiona’ls
background important.
Discussion
With the help of a modified five-round RAND Delphi-
procedure, we were able to develop an internationally vali-
dated set of QIs for the organisation of palliative care with
high face validity as judged by experts in the field of can-
cer and dementia care. The final set provides 23 quality
aspects regarding the accessibility of the service, its infra-
structure, the use of symptom assessment tools, manage-
ment of personnel, documentation of clinical data, quality
of care, and education. Of these 23 QIs, one was identical
to the original one (Family members and friends are able
to visit the dying person without restrictions of visiting
hours), [12] two were new (Family and caregiver experi-
ences of the palliative care service are assessed/evaluated/
recorded and An end-of-life care pathway (such as the
Liverpool Care Pathway) was used for the last 3 days of
life of a person in need of palliative care) and 20 were
rephrased QIs. Panellist agreed not to formulate disease-
specific QIs for the organisation of palliative care, since
our set of QIs provide information about the organisation
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Table 3 Overview of QIs
1. Access to palliative care
1a. Access and availability
1. A specialist palliative care team* is available 24/7.
2. Specialist palliative care* advice is available 24/7 to professionals delivering palliative care.
3. Bereaved relatives and/or professionals involved in care of a person in need of palliative care are offered support during the bereavement
process if they need or wish to have support.
1b. Out of hours care
4. Opioids are accessible and available for persons in need of palliative care 24/7.
5. Co-analgesics* for symptom control are available to treat persons in need of palliative care 24/7.
1c. Continuity of care
6. An (electronic) file of a person in need of palliative care is accessible to professionals in charge of the person 24/7.
7. At each transition between care settings, comprehensive information (including care goals and care plan) of a person in need of palliative
care is be transferred to the professional(s) in charge in the next setting.
8. The professional in charge of the person is informed before a person in need of palliative care is discharged home or sent to the next setting.
9. Persons in need of palliative care have an assigned contact person who maintains regular contact with the person and their families, and
ensures coordinated delivery of health and social care.
2. Infrastructure
10. Specialised equipment (e.g. anti decubitus mattresses, suction equipment, stoma care, oxygen delivery, drug administration pumps, hospital
beds, etc.) is available to persons in need of palliative care.
11. Single bedrooms are available for persons who are dying and who wish to have one.
12. Family members and friends are able to visit the dying person without restrictions of visiting hours.
13. There are facilities for relatives to stay overnight with their dying relative.
14. There is a private area for saying goodbye to the deceased, nearby or on the ward/unit where the person died.
3. Assessment tools
15. There is a regular assessment of pain and other symptoms using a validated instrument*.
4. Personnel
4a. Team
16. The multidisciplinary team* that delivers palliative care services consists of at least:
a) a physician and nurse;
b) and has access to one or more of the following professionals: physiotherapist, psychologist, occupational therapist, social worker, chaplain, dietician.
17. There is a weekly multidisciplinary meeting with at least the physician and nurse in charge of the person in need of palliative care to review
treatment and care plans.
4b. Sharing information
18. The file of the person in need of palliative care contains documentation of a discussion with the person or representative (if the person lacks
capacity e.g. is unable to communicate) about:
a) medical condition;
b) goals for treatment;
c) the physical*, psychosocial and spiritual needs of the person and family caregiver;
d) an advance directive or advanced care plan;
e) end-of-life decisions*;
f) the intention to return home or to another facility from the place where the person is currently staying.
5. Documentation of clinical data
5a. Clinical records
19. The file of the person in need of palliative care contains a medication list that is accessible to the professionals caring for the person.
5b. Timely documentation
20. Within 48 hours of admission to the service, the file of the person in need of palliative care contains documentation of the initial assessment of:
a) pain and other symptoms, using a validated instrument*;
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of services and not about the care provision itself. This
might explain why so many QIs were rated face-valid for
as well the organisation of cancer as dementia palliative
care: regarding aspects as access to and 24 h availability of
specialist palliative care or transferring information be-
tween settings, the specific condition of the patient (ad-
vanced cancer, dementia, or even COPD or heart failure)
is not relevant, making our set of QIs much more broadly
applicable. Therefore, these QIs are generically applicable
and can be used in different settings. Thereby, they can
also be used for (cross-)national comparisons and to
identify best practices regarding the organisation of pallia-
tive care in other services and countries.
In the recent literature several sets of QIs for palliative
care have been identified [11,12,17,38,55]. For example,
Pastrana et al. used a nominal group technique to iden-
tify indicators for the assessment and evaluation of pal-
liative care [38]. However, they primarily focused on the
German health care system, which makes this set diffi-
cult to apply in an international context [38]. Pasman
et al. conducted a literature review, and identified 142
QIs in 16 studies [11]. However, this set also has not
Table 3 Overview of QIs (Continued)
b) psychosocial and spiritual needs;
c) persons preferences, wishes and needs;
d) capacity to be involved in the decision making process.
6. Quality
21. Family and caregiver experiences of the palliative care service are assessed/evaluated/recorded.
22. An end-of-life care pathway (such as the Liverpool Care Pathway) was used for the last 3 days of life of a person in need of palliative care.
7. Education
23. All professionals that deliver palliative care services receive accredited training in palliative care, appropriate to their discipline.
NB Where person is stated, one can also read patient.
Glossary
Palliative care team: A home palliative care team provides specialised palliative care* to patients who need it at home (or home replacing institute) and
support to their families and carers at the patient’s home. They also provide specialist advice to general practitioners, family doctors and nurses caring for the
patient at home. The core team of a home palliative care team consists of four to five full-time professionals and comprises physicians and nurses with
specialist training, a social worker and administrative staff. The home palliative care team works in close collaboration with other professionals so that the full
range of multi-professional team work can be realised in the home-care setting. (Source: Radbruch L, Payne S: White paper on standards and norms for
hospice and palliative care in Europe: part 2. European Journal for Palliative Care 2010, 17:22–33).
A hospital palliative care support team provide specialist palliative care* advice and support to other clinical staff, patients and their families and
carers in the hospital environment. They offer formal and informal education, and liaise with other services in and out of the hospital. A hospital
palliative care support team is composed of a multiprofessional team with at least one physician and one nurse with specialist palliative care training.
The team should have ready access to other professionals working in liaison with it, including bereavement specialists, chaplains, dietitians, therapists,
oncologists, pharmacists, physiotherapists, psychiatrists, psychologists, social workers and speech and language therapists. (Source: Radbruch L, Payne S:
White paper on standards and norms for hospice and palliative care in Europe: part 2. European Journal for Palliative Care 2010, 17:22–33).
A team is hereby defined as a group of people organized to work together, which consists of at least a nurse and a physician.
Specialist palliative care: Specialist palliative care is provided by specialised services for patients with complex problems not adequately covered by
other treatment options. Specialist palliative services require a team approach, combining a multiprofessional team with an interdisciplinary mode of
work. Team members must be highly qualified and should have their main focus of work in palliative care. (Source: Radbruch L, Payne S: White paper
on standards and norms for hospice and palliative care in Europe: part 2. European Journal for Palliative Care 2010, 17:22–33).
Co-analgesics: An adjuvant (or co-analgesic) is a drug that in its pharmacological characteristic is not necessarily primarily identified as an analgesic
in nature, but that has been found in clinical practice to have either an independent analgesic effect or the additive analgesic properties when used
with opioids. (Source: Khan M.I.A., Walsh D., Brito-Dellan N: Opioid and Adjuvant Analgesics: Compared and Contrasted. AM J HOSP PALLIAT CARE
2011, 28(5) 378–383)
Validated instrument: Instruments such as the Visual Analogue Scale (VAS) or the Numeric Rating Scale (NRS) that can be used to indicate the
severity of the patient’s pain or other symptom. (Source: Ahmedzai S, Gómez-Batiste X, Engels Y, Hasselaar J, Jaspers B, Leppert W, Menten J, Mollard JM,
Vissers K: Assessing Organisations to Improve Palliative Care in Europe. Nijmegen: Vantilt Publishers; 2010).
End-of-life decisions: End-of-life care may be used synonymously with palliative care or hospice care, with end of life understood as an extended
period of one to two years during which the patient/family and health professionals become aware of the life-limiting nature of their illness.
End-of-life care may also be understood more specifically as comprehensive care for dying patients in the last few hours or days of life. Either
way, the patient preserves his/her self-determination regarding the power of decision on place of care, treatment options and access to specialist
(palliative) care. End-of-life decisions are all the decisions made by the patient/family and health professionals regarding this last phase of a patient’s life,
e.g. decisions that may influence the time of death, either prolonging life (or prolonging dying) or shortening life (or let patients die). (Source: Radbruch L,
Payne S: White paper on standards and norms for hospice and palliative care in Europe: part 1. European Journal for Palliative Care
2010, 16(6):278–289).
Physical needs: For example if the patients physical symptoms require certain needs, such as special bed, walking aid, etc.
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been developed within an international context and it
does not focus on the organisation of palliative care [11].
An update of this review, published in 2013, included a
further 187 QIs, bringing the total to 326 QIs, with still
few QIs about the organisation of palliative care [55].
Around the same time, Woitha et al. developed a set of 56
QIs [12,17]. Woitha et al. conducted two written Delphi
rounds, leaving little room for discussion, while we con-
ducted a consensus round with extensive opportunity to
discuss the QIs. Secondly, they included professionals
from different European countries only, while we also in-
cluded professionals from countries such as Canada,
Australia and the USA, making the set of QIs presented
here globally applicable. Thirdly, they focused on the or-
ganisation of palliative care in general and did not specif-
ically consider the organisation of palliative care for
patients with dementia, like was done in the present
study.
A recently published White paper defining optimal pal-
liative care in older people with dementia, [56] described
several recommendations on palliative care treatment for
persons with dementia. All of their recommendations that
can be translated to the organisation of care, like the use
of assessment tools, multidisciplinary meetings, bereave-
ment support and about specialist palliative care teams,
are represented in our QI set.
Another quality indicator, suggested by the World
Health Organization as part of the framework programme
on non-communicable diseases has been the focus of at-
tention recently. This QI is being proposed to describe ac-
cess to palliative care by assessing morphine equivalent
consumption per death from cancer [57,58]. However, this
QI has been criticized as it might have provided flawed in-
formation due to inaccuracies in the underlying data base
and the unavailability of national cancer registries [59]. In-
stead of assessing palliative care on a global level, we aim
to assess whether palliative care services meet a basic
quality level or higher quality level that would be met only
in very good practices. Our set of QIs can therefore be
used as internal QIs by health care providers (profes-
sionals and managers) to monitor and improve their ser-
vice. They can also be used to describe and rank services
according to performance, but this should not lead to a
quality rating, as there may be good reasons for the differ-
ences in performance with the QI (e.g. different organisa-
tional structure).
Using our QIs as an external quality assessment tool
will therefore make them unfit for their task [60]. Ber-
wick et al. summarized this as ‘measuring for improve-
ment is not measuring for judgement’ [61]. An ongoing
intervention in 40 palliative care services in Europe, in-
cluding hospitals, hospices, nursing homes and primary
care settings, performed as part of the IMPACT pro-
ject, in which this set of QIs is used as starting point to
assess the organisation of palliative care, will evaluate
the feasibility and discriminatory power of the QIs in
relation to improving the organisation of palliative care
in the participating services.
Strengths and limitations
Strengths of this study were that we used a large inter-
national group of panellists for our Delphi procedure, who
were actively involved in palliative care (such as members
of the European Association for Palliative Care). Secondly,
by organising our consensus meeting during the EAPC
Congress in Trondheim, Norway, key persons active in
the fields of palliative care and dementia care were able to
contribute extensively to the discussion of the Delphi pro-
cedure. Thirdly, the multidisciplinary character of pallia-
tive care was represented by the panellists (e.g. physicians,
nurses, psychologists, etc.) involved in the Delphi proced-
ure. Furthermore, half of them were professionals active
in dementia care. Fourth, combining QIs for the organisa-
tion of services that provide care to palliative patients with
cancer and those that provide such care to patients with
dementia is unique. Our QIs can therefore be used in dif-
ferent settings.
A limitation of this study is that this set of QIs might
not be comprehensive. Because an international, gen-
eric set of QIs was developed, some QIs that were im-
portant in only one or a few countries were excluded
from the list. For that reason, important national or
setting-specific QIs must be added when the set is used
in a specific country. Secondly, this set of QIs is only
related to the organisation of palliative care. Outcome
and patient-related outcome measures were not in-
cluded because they address a distinct purpose in meas-
uring quality of palliative care. Thirdly, participants of
the modified RAND Delphi procedure were selected
because of their knowledge about palliative care, cancer
care or dementia care. Because some experts of two
large European networks (EAPC and InterDem) are
part of the IMPACT consortium, they were also se-
lected as participant for the modified RAND Delphi
procedure (n = 18). Although not all countries were
represented (like France) and others were overrepre-
sented (like the Netherlands), the experts covered 12
countries from three continents, covering different
health care systems and types of organisation of pallia-
tive care. Pilot testing the set of QIs in those countries
and continents that were not represented in this study
will reveal whether they are applicable in these coun-
tries too. Fourthly, unfortunately, there were no patient
representatives involved as panellist. Testing the final
set of QIs will therefore also have to incorporate their
views on the basic quality level or higher quality level
that would be met only in very good services.
van Riet Paap et al. BMC Health Services Research 2014, 14:396 Page 8 of 10
http://www.biomedcentral.com/1472-6963/14/396
Conclusion
International experts selected a set of 23 QIs for the
organisation of palliative care that can be implemented
in daily practice in order to demonstrate that organisa-
tions are providing high quality and effective palliative
care or to identify areas for improvement.
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